Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-18

Clinical Trial Update: Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating GL0034's efficacy and safety in overweight or obese adults with Type 2 diabetes mellitus, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GL0034

Snippet

Sponsor: Sun Pharmaceutical Industries Limited | Conditions: Type II Diabetes Mellitus | Phase 2 | Status: RECRUITING